MERYL NASS, MD

⁦⁩More human #H5N1 cases w/ increasing severity is great concern. ⁦@CAgovernor⁩ emergency declaration is exactly the right move to help get in front of the outbreak. ⁦@FortuneMagazine⁩ ⁦@cbarbermd⁩ ⁦@GavinNewsom⁩ fortune.com/well/2024/12/1…

Jefferey Jaxen Investigates Series Premiere! TOMORROW, 12/19, 5 pm PT (8 pm ET) Episode 1 - 'Polio: The Founding Myth of Modern Medicine, PT 1' JJI Investigates long-held assumptions of modern medicine, science, society, and more. Go to HIGHWIRE.PLUS, and for a small monthly donation, you'll have access to this premier, more shows, and SO MUCH MORE. See you tomorrow for the premier on HighWire+! @JeffereyJaxen, @delbigtree, @PierreKory, @forrestmaready

Nicole Shanahan addresses MAHA’s disappointment with Trump pick Brooke Rollins for Agriculture Secretary “I know a lot of farmers out there saw that pick and were really upset.” “It ended up going to Brooke Rollins, who is not someone I’ve ever come across in the agricultural world, certainly not within the regenerative agriculture world. A few weeks ago, there was a committee formed, wonderful, wonderful farmers … who were called by Bobby Kennedy’s team and the MAHA team. There was a committee put together to put together a list of farmers or entrepreneurs or leaders in the agriculture space who we would submit for consideration. True leaders in the soil and regenerative movement put together an exhaustive list. What I heard was that at Mar-a-Lago at the time, there was this horse-trading happening, and Agriculture was put into a different bucket than the HHS departments. I was very loud about that during our suspension of the campaign and endorsing Trump. I had hope that we would get Ag. When it came down to the last few days before the Ag pick was gonna be confirmed, I went out to everybody I knew. I went out to even Steve Bannon, who is literally Donald Trump’s biggest supporter, and he was on board. I was hearing murmurs that at the table at Mar-a-Lago … we got very close. John Kempf even got close to getting the nomination. They loved the idea of a real, regenerative Amish farmer representing an important cabinet position. But something happened, as it always seems to, and we got traded out for Brooke Rollins, who I honestly didn’t know much about, but found out she’s the CEO of America First Policy Institute, which raised $21 million and most of that went to the MAGA PAC. During the first Trump Administration, she was acting Director of the United States Domestic Policy Council. Someone close to that first Administration said, ‘we feel that she may have sabotaged some of MAGA’s efforts in Trump’s first term.’ Quite frankly, I’m not sure what they were referring to. And then I was like, okay, what is her connection to Ag? … And I found out that she did 4-H as a child. So, we have that going for us. I’m gonna be honest. I’m worried, I’m concerned. I’ve heard rumors that maybe our Deputy Secretary of Agriculture might be a MAHA farmer, and I’m gonna hold out hope that this is somebody that we can work with.” @NicoleShanahan

@ScienceWDrDoug En ese sentido, en la cumbre sobre seguridad de las vacunas. Realizado el 2 de Dic del 2019 en la OMS. Estoy esperando aún, el informe de los biomarcadores para descartar reactogenia cruzada entre vacunas y estén lesionando niños. Dudo que auto cuestionen su evangelio.

"A pediatric practice cannot survive...without doing most of the vaccines, if not all of them [on the CDC schedule]...that's the pressure that pediatricians are under...that explains [why] they...won't...look at the fact that these vaccines are causing a lot of harm." Retired pediatrician Dr. Paul Thomas describes during a Children's Health Defense (@ChildrensHD) interview how pediatric practices cannot survive financially without administering the CDC's "vaccine" schedule to patients due to their reliance on federal dollars. For his own practice, Thomas notes that when he (largely) stopped "vaccinating" his patients, he lost more than a million dollars in revenue per year. Thomas notes there are multiple ways that pediatric practices earn federal dollars by "vaccinating" young children, including "admin fees," which one can think of as "a 'Thank you' for giving [a] shot" and handing out an accompanying VIS, or vaccine information sheet. The retired pediatrician notes that for a two-month "Well Baby" visit, there's a DPT shot—which is three shots (three antigens)—a Hib (Haemophilus influenzae type B) shot, a Prevnar (Pneumococcal conjugate vaccine) shot, a Hep B shot, a polio shot, and a rotavirus shot; all in, these amount to six shots and eight antigens. For the pediatrician, this amounts to $240. This figure can then be multiplied by 30 or 40, as that's how many newborns a pediatrician can expect to see in a month. That number is then multiplied again, as those babies are coming in repeatedly at two months, four months, six months, nine months, 12 months, 15 months, and age two. "[I]t's a lot of visits," Thomas says. "And then there's the older kids that need boosters..." Additionally, Thomas notes that "one of the main quality measures is how well you vaccinate." He says, "It has nothing to do with how healthy your kids are," and points out that when he studied his "vaxxed versus unvaxxed patients" he found that "the unvaxxed were so incredibly healthy—they rarely got sick. They rarely would end up in an emergency room or in an hospital with any chronic condition." "So being unvaxxed results in very health kids who don't use a lot of medical dollars—every medical system should want that, but it's reversed...it's bizarre," Thomas adds. As a result of this payment scheme, Thomas says a pediatric practice in the U.S. "cannot stay in business if you're not giving pretty close to the CDC schedule—it just doesn't pencil out economically at all." Thomas goes on to say: "A pediatric practice cannot survive using insurance without doing most of the vaccines, if not all of them [on the CDC schedule]...and that's the pressure that pediatricians are under and...that explains the blinders that they just won't go there and look at the fact that these vaccines are causing a lot of harm."

Response to @nytimes hit piece (Part 1) - polio petition to the FDA: The hit piece begins (and ends) with defending a certain polio vaccine, IPOL, which is not the polio vaccine of old, while playing on fear to distract from the clear safety gaps in licensing this particular product. The hit piece starts with the false claim that I “petitioned the government to revoke its approval of the polio vaccine.” Putting aside that it was actually @ICANdecide's petition, the hit piece never once substantively addresses the reasons for the petition, which, upon reading, is plainly eminently reasonable: icandecide.org/wp-content/upl… ICAN’s petition to the FDA seeks to revoke a particular polio vaccine, IPOL, and only for infants and children and only until a proper trial is conducted, because IPOL was licensed in 1990 by Sanofi based on pediatric trials that, according to FDA, reviewed safety for only three days after injection. fda.gov/media/75695/do… This is not “the polio vaccine” developed by Jonas Salk or Albert Sabin that most people think of. It is instead a product based on an entirely new technology, including growing the polio virus on monkey kidney cells whose chromones were modified to cause them to multiply forever, like cancer, and which ends up in the vial of each dose. As the FDA petition itself explained, with citations: “Moreover, unlike Salk’s vaccine, the virus used in IPOL is ‘grown in vero cells, a continuous line of monkey kidney cells cultivated on microcarriers.’ Vero cells have modified chromosomes which cause them to multiple forever, like cancer cells. These cells are susceptible to infection by dozens of viruses, including HPV, measles, rubella, reovirus, SV40 virus, and SV-5.” icandecide.org/wp-content/upl… And as the FDA approved package insert for IPOL explains: “culture technique and improvements in purification, concentration, and standardization of poliovirus antigen produce a more potent and consistent immunogenic vaccine than the inactivated poliovirus vaccine (IPV) available in the US prior to 1988.” fda.gov/media/75695/do… ICAN’s petition, filed in 2022, makes the reasonable request that the FDA, as required by federal law, require a proper clinical trial for IPOL prior to licensure. This was an eminently reasonable request and one the NYT should support and hail. After all, it claims to care about consumer rights and product safety when writing about other consumer products. But clearly not when it comes to the safety of products now injected into babies 29 times in the first year of life, up from 3 injections in 1986. cdc.gov/vaccines/sched…(1983 CDC schedule); cdc.gov/vaccines/hcp/i…(2025 CDC schedule) Assuring the safety of these injections is critical. Childhood chronic disease has exploded from less than 13% of children in the 1980s to well over 50% of children today, with most of the explosive rise occurring among immune and immune mediated diseases. pubmed.ncbi.nlm.nih.gov/20159870/; cdc.gov/school-health-…; pubmed.ncbi.nlm.nih.gov/21570014/. It is therefore reasonable to ask for proper clinical trials for childhood vaccines, almost all of which, including IPOL, were licensed between 1986 and today, and which are intended to systemically modify the immune system. Instead of focusing on the legitimate request in the petition, the hit piece stokes fear by ironically writing that “In 2022, an unvaccinated man New York became paralyzed after contracting polio,” while failing to mention that this person was infected with the vaccine strain of polio, not the wild polio virus. cdc.gov/mmwr/volumes/7…. The last wild case of polio in the United States was in 1979. This hit piece also fails to mention that, as explained by the CDC, “Inactivated polio vaccine (IPV) [such as IPOL] is the only polio vaccine that has been given in the United States since 2000” and “IPV… protects people from polio disease but does not stop transmission of the virus.” cdc.gov/polio/vaccines…; cdc.gov/poliovirus-con…. ICAN has also given HHS, and its agencies, including FDA, every opportunity to support the claim IPOL was properly trialed before filing its petition. It had an extensive letter exchange with HHS in 2017-2018 in which HHS could not support the safety of the childhood schedule. icandecide.org/article/vaccin…. ICAN filed FOIA requests with FDA for the trial reports to support the safety of IPOL and the reports provided were plainly deficient to support safety. icandecide.org/wp-content/upl…. ICAN also separately carefully evaluated and published regarding the available safety data. icandecide.org/get-informed/. In contrast, the NYT hit piece does not cite any actual data or studies, just anecdotes and unsupported assertions. The hit piece's only response regarding the plainly deficient trial to license IPOL (which again was a novel product, using effectively cancerous cells to grow the virus), does not come from FDA, but rather from a Sanofi representative, the company that makes and profits from selling this product. He claims that there supposedly was more data that the FDA relied upon to license this product. But if that’s true, the FDA licensure documents would have been updated to reflect more than three days of safety review after injection and the FDA would have surely produced it in response to ICAN’s polio petition filed in 2022. Neither has happened. In fact, ICAN already demanded via FOIA that the FDA produce “A copy of the report for each clinical trial relied upon by the FDA when approving IPOL in 1990” and the documents provided in response by FDA make plain ICAN’s petition and safety concern are more than valid, as laid out in ICAN’s petition for the world to read. icandecide.org/wp-content/upl…. But the NYT reporters writing the hit piece plainly do not care about truth and accuracy. If the NYT cared about at all about accuracy, the minimum it should do is update its headline from “Kennedy’s Lawyer Has Asked the F.D.A. to Revoke Approval of the Polio Vaccine”, to “ICAN Has Asked the F.D.A. to Revoke Approval for Children of a New Polio Vaccine, Using New Technology, Licensed in 1990, Until it is Properly Trialed for Safety.” NYT Article: nytimes.com/2024/12/13/hea…